Predicting ovarian mass risk in girls under 16
Part of Skin clinical trials.
This study looks at whether a special scoring system (O-RADS) on MRI scans can help doctors tell if an ovarian mass is cancer or not before surgery. It aims to improve diagnosis and treatment planning for young girls.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a girl under 16 years old.
- You had surgery to remove an ovarian mass at a study hospital.
- You had an MRI before your surgery.
- The tissue from your surgery was examined by a pathologist.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study looks at whether MRI can help doctors better understand ovarian masses found during pregnancy. It aims to improve diagnosis and care for you and your baby.
This study uses ultrasound images to categorize ovarian cysts or masses according to a system called O-RADS, which helps doctors estimate the risk of cancer. It aims to improve how ovarian findings are described and reported, so you and your doctor can make better decisions about next steps.
This study uses computer algorithms to look at ultrasound images of adnexal masses (growths near the ovaries or fallopian tubes) to help predict whether they are likely to be benign or malignant. It aims to improve diagnosis and guide treatment decisions.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
This study compares imaging scans with surgery to see which better predicts if all visible ovarian cancer can be removed. It aims to improve surgical planning for women with primary ovarian cancer.
Hear when a new Ovarian; Mastopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.